Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine-Reference-Cited by-同舟云学术

Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine

Published:2020-04 Issue:18 Volume:38 Page:3489-3500
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Tavares-Da-Silva Fernanda,Co Maribel Miranda,Dessart Christophe,Hervé Caroline,López-Fauqued Marta,Mahaux Olivia,Van Holle Lionel,Stegmann Jens-Ulrich

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference57 articles.

1. Clinical practice: herpes zoster;Cohen;N Engl J Med,2013

2. Systematic review of incidence and complications of herpes zoster: towards a global perspective;Kawai;BMJ Open,2014

3. The global epidemiology of herpes zoster;Yawn;Neurology,2013

4. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction;Yawn;Mayo Clin Proc,2007

5. Clinical practice. Postherpetic neuralgia;Johnson;N Engl J Med,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant system AS01: from mode of action to effective vaccines;Expert Review of Vaccines;2024-08-05

2. Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia;Vaccine;2024-05

3. A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example;Advances in Pharmacological and Pharmaceutical Sciences;2024-01-24

4. COVID-19, Influenza und andere Virusinfektionen: Häufige und manchmal anhaltende Kopfschmerzen;Deutsches Ärzteblatt Online;2023-12-15

5. Efficacy and safety of the recombinant zoster vaccine: A systematic review and meta-analysis;Vaccine: X;2023-12